Advertisement
UK markets open in 5 hours 59 minutes

  • NIKKEI 225

    37,299.55
    -780.15 (-2.05%)
     

  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     

  • CRUDE OIL

    82.60
    -0.13 (-0.16%)
     

  • GOLD FUTURES

    2,392.80
    -5.20 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • Bitcoin GBP

    50,487.55
    +1,003.16 (+2.03%)
     

  • CMC Crypto 200

    1,305.08
    +419.54 (+47.04%)
     

  • NASDAQ Composite

    15,601.50
    -81.87 (-0.52%)
     

  • UK FTSE All Share

    4,290.02
    +17.00 (+0.40%)
     
Money:

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

BUZZ-Shire: shares slump, proposed $30 bln all-stock deal with Baxalta

Reuters - UK Focus

** Shire (Xetra: S7E.DE - news) slides nearly 8 pct after co confirms it made a proposal to merge with Baxalta (Berlin: 9BX.BE - news) in an all-stock deal

** Baxalta shares spike 28.2 pct in the US premarket

** Shire says Baxalta has declined to engage in discussions

** Shire shares poised for worst drop since a deal with AbbVie (Xetra: 4AB.DE - news) was called off last October

** One trader says news likely to dent speculation about Shire getting taken over

** Shire has been an active dealmaker this year with the latest coming a day ago with a $300 mln purchase of U.S.-based Foresight Biotherapeutics

(RM (LSE: RM.L - news) : sudip.kargupta.thomsonreuters.com@reuters.net; RM: alasdair.pal.thomsonreuters.com@reuters.net)